Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.
about
Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathyBiostable ssDNA aptamers specific for Hodgkin lymphomaDiagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.
P2860
Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Whole genome profiling and oth ...... ontributions and future hopes.
@en
type
label
Whole genome profiling and oth ...... ontributions and future hopes.
@en
prefLabel
Whole genome profiling and oth ...... ontributions and future hopes.
@en
P2860
P1433
P1476
Whole genome profiling and oth ...... ontributions and future hopes.
@en
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.179
P478
26 Suppl 1
P50
P577
2013-01-01T00:00:00Z
P5875
P6179
1003252163